Impact of Left Ventricular Assist Devices on Days Alive and Out of Hospital in Hemodynamically Stable Patients with End-Stage Heart Failure: A Propensity Score Matched Study

Impact of Left Ventricular Assist Devices on Days Alive and Out of Hospital in Hemodynamically Stable Patients with End-Stage Heart Failure: A Propensity Score Matched Study

The two main surgical options to treat end-stage heart failure are heart transplantation (HTx) or left ventricular assist device (LVAD) implantation. In hemodynamically stable patients, the decision for HTx listing with or without LVADs is challenging. We analyzed the impact of both options on days...

Full description

Bibliographic Details
Main Authors: Theresa Tenge, Sebastian Roth, René M‘Pembele, Giovanna Lurati Buse, Florian Boenner, Christina Ballázs, Igor Tudorache, Udo Boeken, Artur Lichtenberg, Martin Neukirchen, Ragnar Huhn, Hug Aubin
Format: Article
Language:English
Published: MDPI AG 2022-11-01
Series:Life
Subjects:
heart failure
cardiac surgery
heart transplantation
left ventricular assist devices
patient-centered outcomes
Online Access:https://www.mdpi.com/2075-1729/12/12/1966

Internet

https://www.mdpi.com/2075-1729/12/12/1966

Similar Items